Tuberculosis incidence among infected contacts detected through contact tracing of smear-positive patients

• Published in: PloS one 2019-04, Vol.14 (4), p.e0215322-e0215322
• Main Authors: Martin-Sanchez, Mario, Brugueras, Silvia, de Andrés, Anna, Simon, Pere, Gorrindo, Pilar, Ros, Miriam, Masdeu, Eva, Millet, Joan-Pau, Caylà, Joan A, Orcau, Àngels
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Analysis; Biology and Life Sciences; Biomedical research; Child; Child, Preschool; Confidence intervals; Contact tracing; Development and progression; Diagnosis; Disease; Disease transmission; Epidemiology; Female; Follow-Up Studies; Health aspects; Health care; Health risks; Humans; Incidence; Infections; Internet; Latent Tuberculosis - drug therapy; Latent Tuberculosis - mortality; Latent Tuberculosis - transmission; Male; Medicine and Health Sciences; Middle Aged; Population; Population studies; Prevention; Preventive medicine; Public health; Pulmonary tuberculosis; Regression analysis; Retrospective Studies; Risk analysis; Risk factors; Smear; Social Sciences; Sociodemographics; Statistical analysis; Statistics; Systematic review; Tuberculosis; Tuberculosis, Pulmonary - drug therapy; Tuberculosis, Pulmonary - mortality; Tuberculosis, Pulmonary - transmission
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0215322

The contacts of people with pulmonary tuberculosis (PTB) have a high risk of becoming infected and developing tuberculosis (TB). Our aim was to determine the incidence of TB and its risk factors in a cohort of contacts with latent TB infection (LTBI) detected through contact tracing of smear-positive PTB cases. We performed a population-based retrospective cohort study including contacts that had LTBI, and were contacts of people with PTB who started treatment between 2008 and 2014. We followed up contacts until they developed TB or until the end date for follow-up (31st December 2016). We used Kaplan-Meier curves to compute incidence at 2 and 5 years, and Cox regression to compute hazard ratios (HR) and their 95% confidence intervals (CI). We analyzed 3097 close contacts of 565 PTB cases. After exclusion of 81 co-prevalent TB cases, 953 contacts had LTBI, of which 14 developed TB. Their risk of developing TB after two and five years was 0.7% (CI: 0.3-1.6) and 1.8% (CI: 1.1-3.1) respectively. Contacts who had not been referred for LTBI treatment had a 1.0% (CI: 0.2-4.0) risk at 5 years. Risk of developing TB at 5 years was 1.2% (CI: 0.5-3.0) among people who completed treatment, and 11.1% (CI: 5.1-23.3) for those who did not. Risk factors for TB were not completing LTBI treatment (HR 9.4, CI: 2.9-30.8) and being female (HR 3.5, CI: 1.1-11-3). LTBI treatment plays a fundamental role in decreasing the risk of developing TB. It is necessary to achieve a maximum contact tracing coverage and the highest possible compliance with LTBI treatment.